The intact human fibroblast has been used in clinical and basic research studies of receptor-mediated control of cell function, however there is little information about the relationship between muscarinic receptor density and the regulation of cyclic AMP (cAMP) 
Introduction
The human fibroblast has been useful in the clinical investigation of a variety of conditions due to its ease of access and its potential for reflecting alterations in central and systemic processes Received for publication 25 March 1985. cyclase system that can be stimulated by prostaglandin and inhibited by stimulation of muscarinic cholinergic receptors (1) . This cell type has been used as a model system for investigations of cholinergic regulation in intact human cells (2, 3) . Skin fibroblasts from individuals with pseudohypoparathyroidism have been shown to be deficient in activity of the guanine-nucleotide regulatory protein associated with the stimulation of adenylate cyclase (4, 5) . It has also been demonstrated that isoproterenol-stimulated accumulation of cAMP in skin fibroblasts from diabetics is twice as high as that of controls (6) . In these clinical studies, it was concluded that the changes seen in the fibroblasts were consistent with similar changes shown in other tissues of the body. More recently, Nadi et al. (7) reported the use of adult skin fibroblasts in a clinical investigation of muscarinic receptor activity in patients with a psychiatric history of major affective illness.
Previous studies in our laboratory have characterized the inhibitory coupling of the a2 adrenergic receptor to adenylate cyclase in the human platelet, and compared receptor binding properties and cAMP production in intact cells (8) . Although muscarinic-mediated inhibition of cAMP accumulation in the human fetal lung fibroblast has been well characterized in the intact cell preparation (1-3), little is known of the muscarinic binding characteristics or the size of the receptor population in these cells. We report here our findings related to the properties of muscarinic receptors on intact human fibroblasts from human lung and skin at two stages of development. These studies have compared the receptor binding characteristics and the muscarinic-mediated inhibition of cAMP accumulation in these various cell types, and have addressed the suitability of the adult skin fibroblast as a model for the muscarinic receptor in clinical investigations.
Methods
Human fetal lung fibroblasts (IMR-90), human fetal skin fibroblasts (AG4392), and adult skin fibroblasts (IMR-GM5225) were obtained from the Institute for Medical Research, Camden, NJ. Adult fibroblasts were obtained locally; skin fibroblasts (DVR, RL, MA) were obtained from 4-mm punch biopsies of the medial aspect of the upper arm, and adult lung fibroblasts were obtained from normal human lung parenchyma. Fibroblasts were isolated in a culture medium of minimal essential medium containing 10% fetal bovine serum, nonessential amino acids, 0.1 mg/ml Na pyruvate, 100 ,g/ml streptomycin, and 100 U/ml penicillin. The cultures were incubated at 37°C in an atmosphere of 5% CO2, 95% air. For subculture of all lines, cells were dissociated with 0.25% trypsin, resuspended in complete medium without nonessential amino acids and Na pyruvate. Stock cultures flasks filled with medium and were passaged at least once before seeding for experiments.
For experiments, cells were seeded in 24-well cluster plates (2 cm2) at a density of 2.5 X 104 per well in I ml medium and incubated for I wk. Cultures were between population doubling levels, 15- For intact cell radioligand binding studies, fibroblasts were grown in 24-well cluster plates as above. The cells were washed with HBSS and the reaction carried out in a final volume of 0.5 ml.
[3Hlquinuclidinyl benzilate (QNB) was added to initiate the reaction and the cells were incubated for 1 h at 250C. Nonspecific binding was determined in the presence of 10MuM QNB. The reaction was terminated by the removal of the [3HJQNB, two rapid washings of the monolayer with cold HBSS, and the addition of 0.5 ml 0.1 N NaOH. Cells were allowed to sit for 1 h at 250C and the contents of the wells were removed to scintillation vials, neutralized, and counted.
In most assays, all cell types were tested simultaneously, but when this was not feasible, fetal lung cells (IMR-90) were always included as a standard.
Results
The addition of POE, to fibroblasts that had been prelabeled with [3H]adenine resulted in the stimulation of cAMP accumulation in all four cell lines ( Fig. 1 A) . The results indicate that the skin cells were more responsive to 10 ,m PGE, than lung cells. The results also suggest that with respect to the lung fibroblasts the fetal cells appeared relatively more sensitive than the adult, and in the skin cells the opposite was true.
The inhibition of PGE,-stimulated cAMP accumulation in the fibroblasts was examined using the muscarinic agonist, carbachol ( Fig. 1 B) . Carbachol at 10 Mm was used as a measure of maximal inhibitory activity after determining carbachol dose-response relationships for inhibition of cAMP accumulation. The results indicate that carbachol inhibited 50-60% of control cAMP accumulation in both fetal and adult lung cells, with only 20% inhibition observed in the fetal skin and insignificant inhibition noted in the adult skin. The apparent lack of inhibitory activity in adult skin fibroblasts was examined in five additional skin cell lines and the results were similar to those shown in Fig. 1 .
The pharmacological specificity of this receptor-mediated inhibition of cAMP accumulation was demonstrated using the muscarinic antagonist, atropine (Table I ). inhibit PGE,-stimulated cAMP accumulation (data not shown).
The results indicated that the relative levels of inhibition shown in Fig. 1 B for the four cell lines were maintained for all the agonists. These findings support the conclusion that these receptors are of the muscarinic type. The muscarinic receptors on the intact fibroblasts were also characterized by conducting saturation binding experiments using the mtuscarinic antagonist [3H]QNB. Representative saturation curves for fetal and adult lung, and fetal skin are shown in Fig. 2 . The Kd and B. values from several experi- Fig. 3 . Simultaneously, [3H]QNB binding to fetal lung fibroblasts was examined and the results of these determinations are also shown in Fig. 3 . The binding to adult skin fibroblasts was of low specificity (Table II) Fig. 4 . This comparison indicates that in the fetal and adult lung fibroblasts, the similarity in the number of muscarinic binding sites is reflected in the similarity of the levels of inhibition of PGE,-sti'mulated cAMP accumulation. The fetal skin cells have a smaller receptor population, and the inhibitory capacity of these cells is correspondingly lower. Consistent with these results, adult skin fibroblasts display minimal capacity to inhibit cAMP accumulation and minimal specific binding of [3H]QNB. We can neither confirm their findings nor account for this discrepancy by any apparent difference in cell growth or assay conditions. Our data, however, do indicate the presence of muscarinic receptors on fetal skin cells and suggest that the expression of these receptors may be lost during development. It is possible that under certain, as yet undefined conditions, receptor activity could be expressed in the adult skin fibroblast, but this must await further study.
Although the adult skin fibroblast shares properties with neuronal cells, such as a high affinity choline uptake system (13) , and has been used in investigations of certain neurological disorders (14, 15) , these cells would appear to be inappropriate as a system for the study of muscarinic receptors in clinical investigations. However, the finding that lung fibroblasts possess classical muscarinic receptor activity throughout maturation while the skin cell type loses this property suggests that the fibroblast may be an interesting model with which to study the ontogenetic development of the muscarinic receptor and its coupling to cellular response in a human cell system.
